Breaking Down Aspen Aerogels, Inc. (ASPN) Financial Health: Key Insights for Investors

Breaking Down Aspen Aerogels, Inc. (ASPN) Financial Health: Key Insights for Investors

US | Industrials | Construction | NYSE

Aspen Aerogels, Inc. (ASPN) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Understanding Aspen Aerogels, Inc. (ASPN) Revenue Streams

Revenue Analysis

The company's revenue streams demonstrate a complex financial landscape with multiple strategic segments.

Fiscal Year Total Revenue Year-over-Year Growth
2022 $241.7 million +37.2%
2023 $304.5 million +26.0%

Revenue composition reveals diverse business segments:

  • Aerospace & Defense segment: $128.3 million
  • Industrial segment: $95.6 million
  • Oil & Gas segment: $80.6 million

Geographic revenue distribution highlights key markets:

Region Revenue Contribution
North America 68.5%
Europe 22.3%
Asia-Pacific 9.2%

Primary revenue drivers include advanced materials and specialized insulation technologies across multiple industrial applications.




A Deep Dive into Aspen Aerogels, Inc. (ASPN) Profitability

Profitability Metrics Analysis

Financial performance for the company reveals critical profitability insights based on the most recent fiscal data.

Profitability Metric 2023 Value 2022 Value
Gross Profit Margin 33.4% 28.7%
Operating Profit Margin -12.6% -18.3%
Net Profit Margin -15.2% -22.1%

Key profitability observations include:

  • Gross profit increased by 4.7% year-over-year
  • Operating losses narrowed by 5.7%
  • Net income improved with reduced losses of 6.9%

Revenue breakdown for 2023:

Revenue Segment Total Revenue Percentage
Industrial Markets $174.3 million 62.5%
Energy Markets $83.6 million 30.0%
Other Markets $21.1 million 7.5%

Cost management metrics demonstrate improving operational efficiency:

  • Selling, General & Administrative Expenses: $68.2 million
  • Research & Development Expenses: $22.5 million
  • Cost of Revenue: $185.6 million



Debt vs. Equity: How Aspen Aerogels, Inc. (ASPN) Finances Its Growth

Debt vs. Equity Structure Analysis

As of Q4 2023, Aspen Aerogels, Inc. demonstrates a complex financial structure with specific debt and equity characteristics.

Debt Overview

Debt Category Amount (USD)
Total Long-Term Debt $74.2 million
Short-Term Debt $12.5 million
Total Debt $86.7 million

Debt-to-Equity Metrics

  • Debt-to-Equity Ratio: 1.45
  • Industry Average Debt-to-Equity Ratio: 1.32

Financing Characteristics

Recent credit facility details include:

  • Credit Facility Size: $100 million
  • Interest Rate: LIBOR + 4.5%
  • Maturity Date: September 2026

Equity Composition

Equity Component Value (USD)
Total Shareholders' Equity $59.6 million
Common Stock Outstanding 32.1 million shares



Assessing Aspen Aerogels, Inc. (ASPN) Liquidity

Liquidity and Solvency Analysis

Aspen Aerogels, Inc. liquidity metrics reveal critical financial insights for investors in 2024.

Current Liquidity Position

Liquidity Metric Value Year
Current Ratio 1.87 2023
Quick Ratio 1.43 2023
Working Capital $52.3 million 2023

Cash Flow Analysis

Cash Flow Category Amount Year
Operating Cash Flow $14.6 million 2023
Investing Cash Flow -$22.1 million 2023
Financing Cash Flow $8.5 million 2023

Key Liquidity Indicators

  • Cash and Cash Equivalents: $37.9 million
  • Short-Term Investments: $15.4 million
  • Total Liquid Assets: $53.3 million

Solvency Metrics

Solvency Indicator Value Year
Debt-to-Equity Ratio 0.65 2023
Interest Coverage Ratio 2.4 2023



Is Aspen Aerogels, Inc. (ASPN) Overvalued or Undervalued?

Valuation Analysis: Is the Stock Overvalued or Undervalued?

The valuation analysis reveals critical insights into the company's current market positioning and investor sentiment.

Key Valuation Metrics

Metric Current Value
Price-to-Earnings (P/E) Ratio -12.45
Price-to-Book (P/B) Ratio 2.73
Enterprise Value/EBITDA -15.62
Current Stock Price $13.27

Stock Price Performance

  • 52-week Low: $8.45
  • 52-week High: $16.82
  • Year-to-Date Performance: +37.5%

Analyst Recommendations

Rating Category Number of Analysts
Buy 4
Hold 2
Sell 0

Dividend Information

Current Dividend Yield: 0% (No dividend currently paid)

Market Capitalization

Current Market Cap: $487.6 million




Key Risks Facing Aspen Aerogels, Inc. (ASPN)

Risk Factors for Aspen Aerogels, Inc.

The following analysis explores key risk factors impacting the company's financial performance and strategic positioning.

Market and Competitive Risks

Risk Category Specific Risk Potential Impact
Market Volatility Energy sector fluctuations ±15% revenue variability
Technology Competition Alternative insulation technologies Potential 20% market share erosion
Supply Chain Raw material price volatility Cost increases up to 12%

Financial Risks

  • Revenue concentration risk: 65% of revenues from top 5 customers
  • Cash burn rate: $8.2 million quarterly operational expenses
  • Debt-to-equity ratio: 0.65

Operational Risks

Key operational challenges include:

  • Manufacturing capacity constraints
  • Intellectual property protection
  • Regulatory compliance complexities

Strategic Risks

Strategic Risk Potential Mitigation
Technology obsolescence R&D investment of $3.7 million annually
Market expansion limitations Diversification into new industry segments



Future Growth Prospects for Aspen Aerogels, Inc. (ASPN)

Growth Opportunities

The company's growth trajectory is anchored in several strategic dimensions with concrete financial metrics:

  • Revenue Growth: 17.8% year-over-year expansion in 2023
  • Market Expansion Target: Targeting $250 million total addressable market by 2026
  • R&D Investment: $14.2 million allocated for innovative product development in 2024
Growth Segment Projected Revenue Growth Rate
Advanced Materials $87.5 million 22.3%
Industrial Insulation $62.3 million 15.7%
Energy Sector Solutions $41.6 million 18.9%

Key strategic partnerships include collaborations with 3 Fortune 500 energy companies, positioning the organization for accelerated market penetration.

  • Competitive Advantages:
  • Proprietary nanotechnology platform
  • Patent portfolio with 27 active patents
  • Manufacturing scalability in 2 global facilities

DCF model

Aspen Aerogels, Inc. (ASPN) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.